Does C‐reactive protein identify a subclinical metabolic disease in healthy subjects?
Authors:
- 7 April 2005
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 35 (4) , 265-270
Abstract
Background Highly sensitive C‐reactive protein (hs‐CRP) levels are significant predictors of subsequent diabetes and metabolic syndrome (MS). Owing the strong correlations between components of the MS and obesity with hs‐CRP levels, previous studies about the associations of hs‐CRP with insulin resistance might have been confounded by the inclusion of overweight or dysmetabolic subjects.Design Our aim was to evaluate the associations between hs‐CRP levels and fasting insulin and insulin resistance (evaluated by the Homeostasis Model Assessment: HOMA IR) in a subgroup of subjects with normal body mass index (BMI) and without any metabolic abnormalities. Out of a cohort of 1658 middle‐aged subjects, representative of the local sanitary districts of the province of Asti (north‐western Italy) enrolled for metabolic screening: 241 (14·5%) showed normal BMI, glucose tolerance, blood pressure and waist values and no dyslipidaemia.Results In this subgroup of subjects, those with hs‐CRP levels ≥ 3 mg L−1 showed significantly higher median insulin and HOMA‐IR values (respectively: 20·4 vs. 6·0 pmol L−1, and 0·8 vs. 0·2 µU mL−1× mmol L−1). In a multiple regression model, insulin and insulin resistance remained significantly and independently related to hs‐CRP levels, after adjustments for age, sex, BMI, waist, alcohol consumption, level of physical activity and smoking habits. Very few individuals within lower fasting insulin quartiles showed hs‐CRP values ≥ 3 mg L−1 when compared with approximately 60% of those within the highest quartile.Conclusions The novel finding is that a state of low‐grade systemic inflammation is present in normal BMI subjects who show subclinical insulin resistance but no other metabolic abnormalities.Keywords
This publication has 30 references indexed in Scilit:
- Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?Circulation, 2004
- Distribution and Correlates of C-Reactive Protein Concentrations among Adult US WomenClinical Chemistry, 2004
- C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 DiabetesDiabetes Care, 2002
- Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South AsiansInternational Journal of Obesity, 2001
- Markers of Inflammation and Cellular Adhesion Molecules in Relation to Insulin Resistance in Nondiabetic Elderly: The Rotterdam StudyThe Journal of Clinical Endocrinology & Metabolism, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Physiological Analysis of Middle-Aged and Old Former AthletesCirculation, 1968